APO Research
Talk to an analyst

APO RESEARCH · REPORT

Large Volume Parenteral (LVP)

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Selected research

Market Outlook & Growth Opportunities

Global Large Volume Parenteral (LVP) Market Outlook and Growth Opportunities 2026

19 December 2025201 pages

Choose your research edition.

Industry ResearchLarge Volume Parenteral (LVP) Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Large Volume Parenteral (LVP) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Large Volume Parenteral (LVP) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Large Volume Parenteral (LVP) Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Large Volume Parenteral (LVP) Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

This report provides an overview of the global Large Volume Parenteral (LVP) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Large Volume Parenteral (LVP) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Large Volume Parenteral (LVP) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Large Volume Parenteral (LVP) market size, projected growth trends, production technologies, key applications, and end-use industries.

Large Volume Parenteral (LVP) Segment by Company

Baxter Healthcare

Kelun Pharma

B. Braun

Fresenius

Teva Pharmaceutical Industries

Pfizer (Hospira)

Ostuka Pharmaceutical

CR Double-Crane

Pisa

Huaren

Patheon

Beximco Pharma

Albert David

PSI Ltd

Ozon Pharmaceuticals

BAG Healthcare

BML Parenteral Drugs

Large Volume Parenteral (LVP) Segment by Type

Soft Bag LVP

Plastic Bottle LVP

Glass Bottle LVP

Large Volume Parenteral (LVP) Segment by Application

Basic Infusion

Therapeutic Infusion

Nutritious Infusion

Large Volume Parenteral (LVP) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Large Volume Parenteral (LVP) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Large Volume Parenteral (LVP) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Large Volume Parenteral (LVP) significant trends, drivers, influence factors in global and regions.

6. To analyze Large Volume Parenteral (LVP) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Large Volume Parenteral (LVP) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Large Volume Parenteral (LVP) industry.

Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Large Volume Parenteral (LVP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Large Volume Parenteral (LVP) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Large Volume Parenteral (LVP) Industry Trends Table 2. Large Volume Parenteral (LVP) Industry Drivers Table 3. Large Volume Parenteral (LVP) Industry Opportunities and Challenges Table 4. Large Volume Parenteral (LVP) Industry Restraints Table 5. Global Large Volume Parenteral (LVP) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Large Volume Parenteral (LVP) Revenue Share by Company (2021-2026) Table 7. Global Large Volume Parenteral (LVP) Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Large Volume Parenteral (LVP) Sales Volume Share by Company (2021-2026) Table 9. Global Large Volume Parenteral (LVP) Average Price (US$/K Units) of Company (2021-2026) Table 10. Global Large Volume Parenteral (LVP) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Large Volume Parenteral (LVP) Key Company Manufacturing Base & Headquarters Table 12. Global Large Volume Parenteral (LVP) Company, Product Type & Application Table 13. Global Large Volume Parenteral (LVP) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Soft Bag LVP Table 18. Significant Companies of Plastic Bottle LVP Table 19. Significant Companies of Glass Bottle LVP Table 20. Global Large Volume Parenteral (LVP) Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Large Volume Parenteral (LVP) Sales Volume by Type (2021-2026) & (M Units) Table 22. Global Large Volume Parenteral (LVP) Sales Volume by Type (2027-2032) & (M Units) Table 23. Global Large Volume Parenteral (LVP) Sales Volume Share by Type (2021-2026) Table 24. Global Large Volume Parenteral (LVP) Sales Volume Share by Type (2027-2032) Table 25. Global Large Volume Parenteral (LVP) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Large Volume Parenteral (LVP) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Large Volume Parenteral (LVP) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Large Volume Parenteral (LVP) Sales Value Share by Type (2021-2026) Table 29. Global Large Volume Parenteral (LVP) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Basic Infusion Table 31. Significant Companies of Therapeutic Infusion Table 32. Significant Companies of Nutritious Infusion Table 33. Global Large Volume Parenteral (LVP) Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Large Volume Parenteral (LVP) Sales Volume by Application (2021-2026) & (M Units) Table 35. Global Large Volume Parenteral (LVP) Sales Volume by Application (2027-2032) & (M Units) Table 36. Global Large Volume Parenteral (LVP) Sales Volume Share by Application (2021-2026) Table 37. Global Large Volume Parenteral (LVP) Sales Volume Share by Application (2027-2032) Table 38. Global Large Volume Parenteral (LVP) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Large Volume Parenteral (LVP) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Large Volume Parenteral (LVP) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Large Volume Parenteral (LVP) Sales Value Share by Application (2021-2026) Table 42. Global Large Volume Parenteral (LVP) Sales Value Share by Application (2027-2032) Table 43. Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Large Volume Parenteral (LVP) Sales by Region (2021-2026) & (M Units) Table 45. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2021-2026) Table 46. Global Large Volume Parenteral (LVP) Sales by Region (2027-2032) & (M Units) Table 47. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2027-2032) Table 48. Global Large Volume Parenteral (LVP) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Large Volume Parenteral (LVP) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Large Volume Parenteral (LVP) Sales Value Share by Region (2021-2026) Table 51. Global Large Volume Parenteral (LVP) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Large Volume Parenteral (LVP) Sales Value Share by Region (2027-2032) Table 53. Global Large Volume Parenteral (LVP) Market Average Price (US$/K Units) by Region (2021-2026) Table 54. Global Large Volume Parenteral (LVP) Market Average Price (US$/K Units) by Region (2027-2032) Table 55. Global Large Volume Parenteral (LVP) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Global Large Volume Parenteral (LVP) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Large Volume Parenteral (LVP) Sales by Country (2021-2026) & (M Units) Table 58. Global Large Volume Parenteral (LVP) Sales Market Share by Country (2021-2026) Table 59. Global Large Volume Parenteral (LVP) Sales by Country (2027-2032) & (M Units) Table 60. Global Large Volume Parenteral (LVP) Sales Market Share by Country (2027-2032) Table 61. Global Large Volume Parenteral (LVP) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Large Volume Parenteral (LVP) Sales Value Market Share by Country (2021-2026) Table 63. Global Large Volume Parenteral (LVP) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Large Volume Parenteral (LVP) Sales Value Market Share by Country (2027-2032) Table 65. Baxter Healthcare Company Information Table 66. Baxter Healthcare Business Overview Table 67. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 68. Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio Table 69. Baxter Healthcare Recent Development Table 70. Kelun Pharma Company Information Table 71. Kelun Pharma Business Overview Table 72. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 73. Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio Table 74. Kelun Pharma Recent Development Table 75. B. Braun Company Information Table 76. B. Braun Business Overview Table 77. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 78. B. Braun Large Volume Parenteral (LVP) Product Portfolio Table 79. B. Braun Recent Development Table 80. Fresenius Company Information Table 81. Fresenius Business Overview Table 82. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 83. Fresenius Large Volume Parenteral (LVP) Product Portfolio Table 84. Fresenius Recent Development Table 85. Teva Pharmaceutical Industries Company Information Table 86. Teva Pharmaceutical Industries Business Overview Table 87. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 88. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio Table 89. Teva Pharmaceutical Industries Recent Development Table 90. Pfizer (Hospira) Company Information Table 91. Pfizer (Hospira) Business Overview Table 92. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 93. Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio Table 94. Pfizer (Hospira) Recent Development Table 95. Ostuka Pharmaceutical Company Information Table 96. Ostuka Pharmaceutical Business Overview Table 97. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 98. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio Table 99. Ostuka Pharmaceutical Recent Development Table 100. CR Double-Crane Company Information Table 101. CR Double-Crane Business Overview Table 102. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 103. CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio Table 104. CR Double-Crane Recent Development Table 105. Pisa Company Information Table 106. Pisa Business Overview Table 107. Pisa Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 108. Pisa Large Volume Parenteral (LVP) Product Portfolio Table 109. Pisa Recent Development Table 110. Huaren Company Information Table 111. Huaren Business Overview Table 112. Huaren Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 113. Huaren Large Volume Parenteral (LVP) Product Portfolio Table 114. Huaren Recent Development Table 115. Patheon Company Information Table 116. Patheon Business Overview Table 117. Patheon Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 118. Patheon Large Volume Parenteral (LVP) Product Portfolio Table 119. Patheon Recent Development Table 120. Beximco Pharma Company Information Table 121. Beximco Pharma Business Overview Table 122. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 123. Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio Table 124. Beximco Pharma Recent Development Table 125. Albert David Company Information Table 126. Albert David Business Overview Table 127. Albert David Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 128. Albert David Large Volume Parenteral (LVP) Product Portfolio Table 129. Albert David Recent Development Table 130. PSI Ltd Company Information Table 131. PSI Ltd Business Overview Table 132. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 133. PSI Ltd Large Volume Parenteral (LVP) Product Portfolio Table 134. PSI Ltd Recent Development Table 135. Ozon Pharmaceuticals Company Information Table 136. Ozon Pharmaceuticals Business Overview Table 137. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 138. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio Table 139. Ozon Pharmaceuticals Recent Development Table 140. BAG Healthcare Company Information Table 141. BAG Healthcare Business Overview Table 142. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 143. BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio Table 144. BAG Healthcare Recent Development Table 145. BML Parenteral Drugs Company Information Table 146. BML Parenteral Drugs Business Overview Table 147. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 148. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio Table 149. BML Parenteral Drugs Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Large Volume Parenteral (LVP) Distributors List Table 153. Large Volume Parenteral (LVP) Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Large Volume Parenteral (LVP) Product Image Figure 2. Global Large Volume Parenteral (LVP) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Large Volume Parenteral (LVP) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Large Volume Parenteral (LVP) Sales (2021-2032) & (M Units) Figure 5. Global Large Volume Parenteral (LVP) Sales Average Price (US$/K Units) & (2021-2032) Figure 6. Global Large Volume Parenteral (LVP) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Soft Bag LVP Image Figure 10. Plastic Bottle LVP Image Figure 11. Glass Bottle LVP Image Figure 12. Global Large Volume Parenteral (LVP) Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Large Volume Parenteral (LVP) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Large Volume Parenteral (LVP) Sales Volume Share by Type (2021-2032) Figure 15. Global Large Volume Parenteral (LVP) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Large Volume Parenteral (LVP) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Large Volume Parenteral (LVP) Sales Value Share by Type (2021-2032) Figure 18. Basic Infusion Image Figure 19. Therapeutic Infusion Image Figure 20. Nutritious Infusion Image Figure 21. Global Large Volume Parenteral (LVP) Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Large Volume Parenteral (LVP) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Large Volume Parenteral (LVP) Sales Volume Share by Application (2021-2032) Figure 24. Global Large Volume Parenteral (LVP) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Large Volume Parenteral (LVP) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Large Volume Parenteral (LVP) Sales Value Share by Application (2021-2032) Figure 27. Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 28. Global Large Volume Parenteral (LVP) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Large Volume Parenteral (LVP) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Large Volume Parenteral (LVP) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Large Volume Parenteral (LVP) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Large Volume Parenteral (LVP) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Large Volume Parenteral (LVP) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Large Volume Parenteral (LVP) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Large Volume Parenteral (LVP) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Large Volume Parenteral (LVP) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Large Volume Parenteral (LVP) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Large Volume Parenteral (LVP) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Large Volume Parenteral (LVP) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Large Volume Parenteral (LVP) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Large Volume Parenteral (LVP) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Large Volume Parenteral (LVP) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Soft Bag LVP
  • Plastic Bottle LVP
  • Glass Bottle LVP
Applications
  • Basic Infusion
  • Therapeutic Infusion
  • Nutritious Infusion
Companies covered
  • Baxter Healthcare
  • Kelun Pharma
  • B. Braun
  • Fresenius
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Ostuka Pharmaceutical
  • CR Double-Crane
  • Pisa
  • Huaren
  • Patheon
  • Beximco Pharma
  • Albert David
  • PSI Ltd
  • Ozon Pharmaceuticals
  • BAG Healthcare
  • BML Parenteral Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Large Volume Parenteral (LVP) Sales Value (2021-2032)
  4. 1.2.2 Global Large Volume Parenteral (LVP) Sales Volume (2021-2032)
  5. 1.2.3 Global Large Volume Parenteral (LVP) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Large Volume Parenteral (LVP) Market Dynamics
  1. 2.1 Large Volume Parenteral (LVP) Industry Trends
  2. 2.2 Large Volume Parenteral (LVP) Industry Drivers
  3. 2.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
  4. 2.4 Large Volume Parenteral (LVP) Industry Restraints
3 Large Volume Parenteral (LVP) Market by Company
  1. 3.1 Global Large Volume Parenteral (LVP) Company Revenue Ranking in 2025
  2. 3.2 Global Large Volume Parenteral (LVP) Revenue by Company (2021-2026)
  3. 3.3 Global Large Volume Parenteral (LVP) Sales Volume by Company (2021-2026)
  4. 3.4 Global Large Volume Parenteral (LVP) Average Price by Company (2021-2026)
  5. 3.5 Global Large Volume Parenteral (LVP) Company Ranking (2024-2026)
  6. 3.6 Global Large Volume Parenteral (LVP) Company Manufacturing Base and Headquarters
  7. 3.7 Global Large Volume Parenteral (LVP) Company Product Type and Application
  8. 3.8 Global Large Volume Parenteral (LVP) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Large Volume Parenteral (LVP) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Large Volume Parenteral (LVP) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Large Volume Parenteral (LVP) Market by Type
  1. 4.1 Large Volume Parenteral (LVP) Type Introduction
  2. 4.1.1 Soft Bag LVP
  3. 4.1.2 Plastic Bottle LVP
  4. 4.1.3 Glass Bottle LVP
  5. 4.2 Global Large Volume Parenteral (LVP) Sales Volume by Type
  6. 4.2.1 Global Large Volume Parenteral (LVP) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Large Volume Parenteral (LVP) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Large Volume Parenteral (LVP) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Large Volume Parenteral (LVP) Sales Value by Type
  10. 4.3.1 Global Large Volume Parenteral (LVP) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Large Volume Parenteral (LVP) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Large Volume Parenteral (LVP) Sales Value Share by Type (2021-2032)
5 Large Volume Parenteral (LVP) Market by Application
  1. 5.1 Large Volume Parenteral (LVP) Application Introduction
  2. 5.1.1 Basic Infusion
  3. 5.1.2 Therapeutic Infusion
  4. 5.1.3 Nutritious Infusion
  5. 5.2 Global Large Volume Parenteral (LVP) Sales Volume by Application
  6. 5.2.1 Global Large Volume Parenteral (LVP) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Large Volume Parenteral (LVP) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Large Volume Parenteral (LVP) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Large Volume Parenteral (LVP) Sales Value by Application
  10. 5.3.1 Global Large Volume Parenteral (LVP) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Large Volume Parenteral (LVP) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Large Volume Parenteral (LVP) Sales Value Share by Application (2021-2032)
6 Large Volume Parenteral (LVP) Regional Sales and Value Analysis
  1. 6.1 Global Large Volume Parenteral (LVP) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Large Volume Parenteral (LVP) Sales by Region (2021-2032)
  3. 6.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2021-2026
  4. 6.2.2 Global Large Volume Parenteral (LVP) Sales by Region (2027-2032)
  5. 6.3 Global Large Volume Parenteral (LVP) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Large Volume Parenteral (LVP) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Large Volume Parenteral (LVP) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Large Volume Parenteral (LVP) Sales Value by Region (2027-2032)
  9. 6.5 Global Large Volume Parenteral (LVP) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Large Volume Parenteral (LVP) Sales Value (2021-2032)
  12. 6.6.2 North America Large Volume Parenteral (LVP) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Large Volume Parenteral (LVP) Sales Value (2021-2032)
  15. 6.7.2 Europe Large Volume Parenteral (LVP) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Large Volume Parenteral (LVP) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Large Volume Parenteral (LVP) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Large Volume Parenteral (LVP) Sales Value (2021-2032)
  21. 6.9.2 South America Large Volume Parenteral (LVP) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Large Volume Parenteral (LVP) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Large Volume Parenteral (LVP) Sales Value Share by Country, 2025 VS 2032
7 Large Volume Parenteral (LVP) Country-level Sales and Value Analysis
  1. 7.1 Global Large Volume Parenteral (LVP) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Large Volume Parenteral (LVP) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Large Volume Parenteral (LVP) Sales by Country (2021-2032)
  4. 7.3.1 Global Large Volume Parenteral (LVP) Sales by Country (2021-2026)
  5. 7.3.2 Global Large Volume Parenteral (LVP) Sales by Country (2027-2032)
  6. 7.4 Global Large Volume Parenteral (LVP) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Large Volume Parenteral (LVP) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Large Volume Parenteral (LVP) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Large Volume Parenteral (LVP) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Large Volume Parenteral (LVP) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Large Volume Parenteral (LVP) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter Healthcare
  2. 8.1.1 Baxter Healthcare Company Information
  3. 8.1.2 Baxter Healthcare Business Overview
  4. 8.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
  6. 8.1.5 Baxter Healthcare Recent Developments
  7. 8.2 Kelun Pharma
  8. 8.2.1 Kelun Pharma Company Information
  9. 8.2.2 Kelun Pharma Business Overview
  10. 8.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
  12. 8.2.5 Kelun Pharma Recent Developments
  13. 8.3 B. Braun
  14. 8.3.1 B. Braun Company Information
  15. 8.3.2 B. Braun Business Overview
  16. 8.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
  18. 8.3.5 B. Braun Recent Developments
  19. 8.4 Fresenius
  20. 8.4.1 Fresenius Company Information
  21. 8.4.2 Fresenius Business Overview
  22. 8.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
  24. 8.4.5 Fresenius Recent Developments
  25. 8.5 Teva Pharmaceutical Industries
  26. 8.5.1 Teva Pharmaceutical Industries Company Information
  27. 8.5.2 Teva Pharmaceutical Industries Business Overview
  28. 8.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
  30. 8.5.5 Teva Pharmaceutical Industries Recent Developments
  31. 8.6 Pfizer (Hospira)
  32. 8.6.1 Pfizer (Hospira) Company Information
  33. 8.6.2 Pfizer (Hospira) Business Overview
  34. 8.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
  36. 8.6.5 Pfizer (Hospira) Recent Developments
  37. 8.7 Ostuka Pharmaceutical
  38. 8.7.1 Ostuka Pharmaceutical Company Information
  39. 8.7.2 Ostuka Pharmaceutical Business Overview
  40. 8.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
  42. 8.7.5 Ostuka Pharmaceutical Recent Developments
  43. 8.8 CR Double-Crane
  44. 8.8.1 CR Double-Crane Company Information
  45. 8.8.2 CR Double-Crane Business Overview
  46. 8.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
  48. 8.8.5 CR Double-Crane Recent Developments
  49. 8.9 Pisa
  50. 8.9.1 Pisa Company Information
  51. 8.9.2 Pisa Business Overview
  52. 8.9.3 Pisa Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
  54. 8.9.5 Pisa Recent Developments
  55. 8.10 Huaren
  56. 8.10.1 Huaren Company Information
  57. 8.10.2 Huaren Business Overview
  58. 8.10.3 Huaren Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
  60. 8.10.5 Huaren Recent Developments
  61. 8.11 Patheon
  62. 8.11.1 Patheon Company Information
  63. 8.11.2 Patheon Business Overview
  64. 8.11.3 Patheon Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
  66. 8.11.5 Patheon Recent Developments
  67. 8.12 Beximco Pharma
  68. 8.12.1 Beximco Pharma Company Information
  69. 8.12.2 Beximco Pharma Business Overview
  70. 8.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
  72. 8.12.5 Beximco Pharma Recent Developments
  73. 8.13 Albert David
  74. 8.13.1 Albert David Company Information
  75. 8.13.2 Albert David Business Overview
  76. 8.13.3 Albert David Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
  78. 8.13.5 Albert David Recent Developments
  79. 8.14 PSI Ltd
  80. 8.14.1 PSI Ltd Company Information
  81. 8.14.2 PSI Ltd Business Overview
  82. 8.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
  84. 8.14.5 PSI Ltd Recent Developments
  85. 8.15 Ozon Pharmaceuticals
  86. 8.15.1 Ozon Pharmaceuticals Company Information
  87. 8.15.2 Ozon Pharmaceuticals Business Overview
  88. 8.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
  90. 8.15.5 Ozon Pharmaceuticals Recent Developments
  91. 8.16 BAG Healthcare
  92. 8.16.1 BAG Healthcare Company Information
  93. 8.16.2 BAG Healthcare Business Overview
  94. 8.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
  96. 8.16.5 BAG Healthcare Recent Developments
  97. 8.17 BML Parenteral Drugs
  98. 8.17.1 BML Parenteral Drugs Company Information
  99. 8.17.2 BML Parenteral Drugs Business Overview
  100. 8.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
  102. 8.17.5 BML Parenteral Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Large Volume Parenteral (LVP) Value Chain Analysis
  2. 9.1.1 Large Volume Parenteral (LVP) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Large Volume Parenteral (LVP) Sales Mode & Process
  6. 9.2 Large Volume Parenteral (LVP) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Large Volume Parenteral (LVP) Distributors
  9. 9.2.3 Large Volume Parenteral (LVP) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst